venBio Select Advisor LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:13 am Sale | 2023-12-31 | 13G | MIRATI THERAPEUTICS INC MRTX | venBio Select Advisor LLC | 4,886,840 7.000% | -668,715 (-12.04%) | Filing |
| 2023-02-14 09:34 am Purchase | 2022-12-31 | 13G | MIRATI THERAPEUTICS INC MRTX | venBio Select Advisor LLC | 5,555,555 9.600% | 480,555 (+9.47%) | Filing |
| 2022-02-11 10:01 am Purchase | 2021-12-31 | 13G | MIRATI THERAPEUTICS INC MRTX | venBio Select Advisor LLC | 5,075,000 9.200% | 540,000 (+11.91%) | Filing |